In the German Diabetes and Dialysis Study, high plasma copeptin was associated with increased risk for cardiovascular events (myocardial infarction, stroke, cardiovascular death) and for all-cause mortality in type 2 diabetic patients, but all participants had ESRD and were undergoing hemodialysis [37]. Here, AVP is linked to type 2 diabetes mellitus.